J. Freeman

The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19

Z. Lotfi, A. Hill, R. Tabibi, 2020, The Journal of antimicrobial chemotherapy.

Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low‐ to high‐income settings: making sure no one is left behind

L. Mendão, I. Andrieux-Meyer, Céline Grillon, 2018, Journal of the International AIDS Society.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

The use of generic medications for hepatitis C

A. Hill, J. Freeman, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals

A. Hill, R. Tayyem, Giten Khwairakpam, 2018, Journal of virus eradication.

High Sustained Virological Response Rates Using Generic Direct Acting Antiviral Treatment for Hepatitis C, Imported into Australia

A. Hill, R. Sallie, A. Kennedy, 2016 .